2nd Quarter - Report
FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.
Firm
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General issues related to the rare disease pharmaceutical ecosystem.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| ZACHARY BENJAMIN FRIEND | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.